{"disease":{"id":"arrhythmia","name":"arrhythmia"},"drugs":{"marketed":[{"drug_id":"verapamil-hydrochloride","indication_name":"Arrhythmias","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Verapamil Hydrochloride","company_name":"Pfizer Inc.","drug_phase":"marketed","molecular_target":"L-type calcium channels (slow channels)","drug_class":"Calcium channel blocker","quality_score":56,"revenue":null,"mechanism":"Calcium ion influx inhibitor that modulates ionic calcium across cell membranes of arterial smooth muscle and myocardial cells."},{"drug_id":"flecainide","indication_name":"Documented Ventricular Arrhythmias","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Tambocor","generic_name":"FLECAINIDE","company_name":"","drug_phase":"marketed","molecular_target":"Potassium voltage-gated channel subfamily H member 2","drug_class":"Antiarrhythmic","quality_score":59,"revenue":null,"mechanism":""},{"drug_id":"mexiletine","indication_name":"Ventricular Arrhythmias","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Mexitil","generic_name":"MEXILETINE","company_name":"Boehringer Ingelheim","drug_phase":"marketed","molecular_target":"5-hydroxytryptamine receptor 2B","drug_class":"Antiarrhythmic","quality_score":66,"revenue":null,"mechanism":"Mexitil works by blocking abnormal electrical signals in the heart to restore a normal heartbeat."},{"drug_id":"mexiletine-hydrochloride","indication_name":"Ventricular Arrhythmias","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"MEXILETINE HYDROCHLORIDE","company_name":"","drug_phase":"marketed","molecular_target":"sodium channels","drug_class":"","quality_score":53,"revenue":null,"mechanism":"Mexiletine, an oral antiarrhythmic, reduces ventricular arrhythmias by inhibiting sodium currents and altering refractory periods."},{"drug_id":"flecainide-acetate","indication_name":"Documented Ventricular Arrhythmias","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"FLECAINIDE ACETATE","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":38,"revenue":null,"mechanism":null},{"drug_id":"ajmaline","indication_name":"Cardiac arrhythmia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Ajmalin","generic_name":"AJMALINE","company_name":"","drug_phase":"phase_3","molecular_target":"Potassium voltage-gated channel subfamily A member 5","drug_class":"ajmaline","quality_score":36,"revenue":null,"mechanism":"Ajmaline works by blocking potassium channels in the heart to help regulate heart rhythm."},{"drug_id":"ajmaline","indication_name":"Supraventricular arrhythmia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Ajmalin","generic_name":"AJMALINE","company_name":"","drug_phase":"phase_3","molecular_target":"Potassium voltage-gated channel subfamily A member 5","drug_class":"ajmaline","quality_score":36,"revenue":null,"mechanism":"Ajmaline works by blocking potassium channels in the heart to help regulate heart rhythm."},{"drug_id":"ajmaline","indication_name":"Ventricular arrhythmia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Ajmalin","generic_name":"AJMALINE","company_name":"","drug_phase":"phase_3","molecular_target":"Potassium voltage-gated channel subfamily A member 5","drug_class":"ajmaline","quality_score":36,"revenue":null,"mechanism":"Ajmaline works by blocking potassium channels in the heart to help regulate heart rhythm."},{"drug_id":"bretylium","indication_name":"Ventricular arrhythmia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Bretylium Tosylate","generic_name":"BRETYLIUM","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Beta-1 adrenergic receptor","drug_class":"bretylium","quality_score":36,"revenue":null,"mechanism":""},{"drug_id":"disopyramide","indication_name":"Ventricular arrhythmia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Norpace Cr","generic_name":"DISOPYRAMIDE","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Histamine H1 receptor","drug_class":"Antiarrhythmic","quality_score":50,"revenue":null,"mechanism":""},{"drug_id":"non-interventional-study","indication_name":"Tachyarrhythmia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Non-Interventional Study","generic_name":"non-interventional-study","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Vitamin K epoxide reductase","drug_class":"Anticoagulant","quality_score":25,"revenue":null,"mechanism":""},{"drug_id":"non-interventional-study","indication_name":"Ventricular Arrhythmia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Non-Interventional Study","generic_name":"non-interventional-study","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Vitamin K epoxide reductase","drug_class":"Anticoagulant","quality_score":25,"revenue":null,"mechanism":""},{"drug_id":"moracizine","indication_name":"Ventricular arrhythmia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"moracizine","company_name":"","drug_phase":"unknown","molecular_target":"Sodium channel protein type 5 subunit alpha","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"lignocaine","indication_name":"Ventricular arrhythmia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Lignocaine","company_name":"University of Malaya","drug_phase":"marketed","molecular_target":"5-hydroxytryptamine receptor 3A, Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4, Sodium channel protein type 10 subunit alpha","drug_class":"","quality_score":19,"revenue":null,"mechanism":null},{"drug_id":"mexiletine","indication_name":"Ventricular arrhythmia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Mexitil","generic_name":"MEXILETINE","company_name":"Boehringer Ingelheim","drug_phase":"marketed","molecular_target":"5-hydroxytryptamine receptor 2B","drug_class":"Antiarrhythmic","quality_score":66,"revenue":null,"mechanism":"Mexitil works by blocking abnormal electrical signals in the heart to restore a normal heartbeat."},{"drug_id":"lidocaine-hydrochloride","indication_name":"Ventricular arrhythmia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Lignospan Forte","generic_name":"Lidocaine Hydrochloride","company_name":"Fresenius Kabi","drug_phase":"marketed","molecular_target":"neuronal membrane ionic channels","drug_class":"local anesthetic, amide type","quality_score":68,"revenue":null,"mechanism":"Lidocaine stabilizes neuronal membrane by inhibiting ionic fluxes required for impulse initiation and conduction."},{"drug_id":"ethacizine","indication_name":"Supraventricular arrhythmia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Etacizin","generic_name":"ethacizine","company_name":"","drug_phase":"unknown","molecular_target":"","drug_class":"ethacizine","quality_score":null,"revenue":null,"mechanism":"Etacizin works by blocking potassium channels in the heart, which helps to regulate abnormal heart rhythms."},{"drug_id":"ethacizine","indication_name":"Ventricular arrhythmia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Etacizin","generic_name":"ethacizine","company_name":"","drug_phase":"unknown","molecular_target":"","drug_class":"ethacizine","quality_score":null,"revenue":null,"mechanism":"Etacizin works by blocking potassium channels in the heart, which helps to regulate abnormal heart rhythms."},{"drug_id":"detajmium","indication_name":"Supraventricular arrhythmia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Tachmalcor","generic_name":"detajmium","company_name":"","drug_phase":"unknown","molecular_target":"","drug_class":"detajmium","quality_score":null,"revenue":null,"mechanism":"Tachmalcor works by stabilizing cardiac ion channels to regulate abnormal heart rhythms."},{"drug_id":"detajmium","indication_name":"Ventricular arrhythmia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Tachmalcor","generic_name":"detajmium","company_name":"","drug_phase":"unknown","molecular_target":"","drug_class":"detajmium","quality_score":null,"revenue":null,"mechanism":"Tachmalcor works by stabilizing cardiac ion channels to regulate abnormal heart rhythms."},{"drug_id":"aprindine","indication_name":"Supraventricular arrhythmia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Fiboran","generic_name":"APRINDINE","company_name":"","drug_phase":"marketed","molecular_target":"Cytochrome P450 2D6","drug_class":"aprindine","quality_score":24,"revenue":null,"mechanism":""},{"drug_id":"aprindine","indication_name":"Ventricular arrhythmia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Fiboran","generic_name":"APRINDINE","company_name":"","drug_phase":"marketed","molecular_target":"Cytochrome P450 2D6","drug_class":"aprindine","quality_score":24,"revenue":null,"mechanism":""},{"drug_id":"landiolol","indication_name":"Tachyarrhythmia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Onoact","generic_name":"LANDIOLOL","company_name":"Aop Hlth Us","drug_phase":"marketed","molecular_target":"Beta-1 adrenergic receptor","drug_class":"landiolol","quality_score":37,"revenue":null,"mechanism":"Onoact works by blocking the beta-1 adrenergic receptor, which helps to slow down abnormal heart rhythms."},{"drug_id":"propranolol","indication_name":"Arrhythmias During Surgery","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Inderal","generic_name":"propranolol","company_name":"Generic (originally ICI/AstraZeneca)","drug_phase":"marketed","molecular_target":"Nuclear receptor subfamily 2 group E member 1, 5-hydroxytryptamine receptor 6, Cytochrome P450 1A2","drug_class":"Non-selective beta-blocker","quality_score":45,"revenue":null,"mechanism":""},{"drug_id":"norpace","indication_name":"Documented ventricular arrhythmias","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Norpace Cr","generic_name":"Disopyramide Phosphate","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"G protein-activated inward rectifier potassium channel 4","drug_class":"High Risk QT Prolonging Agents","quality_score":10,"revenue":null,"mechanism":"Norpace is a sodium channel blocker and a Class 1a anti-arrhythmic agent."},{"drug_id":"norpace","indication_name":"Life-threatening ventricular arrhythmias","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Norpace Cr","generic_name":"Disopyramide Phosphate","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"G protein-activated inward rectifier potassium channel 4","drug_class":"High Risk QT Prolonging Agents","quality_score":10,"revenue":null,"mechanism":"Norpace is a sodium channel blocker and a Class 1a anti-arrhythmic agent."},{"drug_id":"prajmalium","indication_name":"Ventricular arrhythmia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Prajmaline","generic_name":"PRAJMALIUM","company_name":"","drug_phase":"phase_2","molecular_target":"","drug_class":"prajmalium","quality_score":null,"revenue":null,"mechanism":"Prajmaline works by blocking sodium channels in the heart, which helps to regulate abnormal heart rhythms."},{"drug_id":"adenosine-triphosphate","indication_name":"Supraventricular arrhythmia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Triphosphoric Acid Adenosine Ester","generic_name":"ADENOSINE TRIPHOSPHATE","company_name":"","drug_phase":"marketed","molecular_target":"P2X purinoceptor 3","drug_class":"Vitamin C [EPC]","quality_score":17,"revenue":null,"mechanism":""},{"drug_id":"lidocain","indication_name":"Ventricular arrhythmia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Lidocain","company_name":"Bayer","drug_phase":"marketed","molecular_target":"5-hydroxytryptamine receptor 3A, Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4, Sodium channel protein type 10 subunit alpha","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"xylocain","indication_name":"Ventricular arrhythmia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"xylocain","company_name":"Saint-Joseph University","drug_phase":"marketed","molecular_target":"5-hydroxytryptamine receptor 3A, Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4, Sodium channel protein type 10 subunit alpha","drug_class":"","quality_score":null,"revenue":null,"mechanism":null}],"pipeline":[],"offLabel":[],"totalMarketed":30,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05837364","title":"Predicting Risk of Atrial Fibrillation and Association With Other Diseases","phase":"","overall_status":"COMPLETED","enrollment_count":2159663,"lead_sponsor_name":"University of Leeds","has_results":false},{"nct_id":"NCT03335800","title":"Apple Heart Study: Assessment of Wristwatch-Based Photoplethysmography to Identify Cardiac Arrhythmias","phase":"NA","overall_status":"COMPLETED","enrollment_count":419927,"lead_sponsor_name":"Apple Inc.","has_results":true},{"nct_id":"NCT03729232","title":"Japanese Catheter Ablation Registry","phase":"","overall_status":"RECRUITING","enrollment_count":400000,"lead_sponsor_name":"National Cerebral and Cardiovascular Center, Japan","has_results":false},{"nct_id":"NCT04426994","title":"Hypomagnesemia Associated With Proton-Pump Inhibitor Use","phase":"","overall_status":"COMPLETED","enrollment_count":211672,"lead_sponsor_name":"Changi General Hospital","has_results":false},{"nct_id":"NCT04024865","title":"Domperidone and Risk of Serious Cardiac Events in Postpartum Women","phase":"","overall_status":"COMPLETED","enrollment_count":184929,"lead_sponsor_name":"Canadian Network for Observational Drug Effect Studies, CNODES","has_results":false},{"nct_id":"NCT03662802","title":"Development of a Novel Convolution Neural Network for Arrhythmia Classification","phase":"","overall_status":"COMPLETED","enrollment_count":25458,"lead_sponsor_name":"Scripps Clinic","has_results":false},{"nct_id":"NCT06001073","title":"Prognosis Prediction System of Patients With Cardiovascular and Cerebrovascular Diseases Based on Multi-omics","phase":"","overall_status":"RECRUITING","enrollment_count":25000,"lead_sponsor_name":"First Affiliated Hospital Xi'an Jiaotong University","has_results":false},{"nct_id":"NCT06884436","title":"Preoperative Cardiology Consultation and the Incidence of Major Adverse Cardiac Events（MACE）","phase":"","overall_status":"COMPLETED","enrollment_count":22000,"lead_sponsor_name":"Chinese PLA General Hospital","has_results":false},{"nct_id":"NCT05645978","title":"Association of Obesity and Cardiovascular Outcomes in Patients With Pacemaker","phase":"","overall_status":"UNKNOWN","enrollment_count":20000,"lead_sponsor_name":"Ajou University School of Medicine","has_results":false},{"nct_id":"NCT05645965","title":"Association of Obesity and Cardiovascular Outcomes in Patients With Implantable Cardioverter-defibrillator (ICD)","phase":"","overall_status":"UNKNOWN","enrollment_count":20000,"lead_sponsor_name":"Ajou University School of Medicine","has_results":false},{"nct_id":"NCT06311149","title":"Multicenter Evaluation of Patients Using LATITUDE Monitoring System","phase":"","overall_status":"RECRUITING","enrollment_count":20000,"lead_sponsor_name":"University Hospital of Ferrara","has_results":false},{"nct_id":"NCT06607471","title":"Multimodal and Multidisciplinary Approach to Optimize Diagnostic, Prognostic, and Therapeutic Management of Patients with Non-ischemic Cardiomyopathies and Arrhythmogenic-inflammatory Phenotypes: a Multicenter, Observational, Retrospective and Prospective Registry Study.","phase":"","overall_status":"RECRUITING","enrollment_count":15000,"lead_sponsor_name":"Scientific Institute San Raffaele","has_results":false},{"nct_id":"NCT06763549","title":"COR-INSIGHT: Optimizing Cardiovascular and Cardiopulmonary Outcomes with AI-Driven Multiplexed Indications Using COR ECG Wearable","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":15000,"lead_sponsor_name":"Peerbridge Health, Inc","has_results":false},{"nct_id":"NCT06847932","title":"Leveraging AI-ECG Technology for Early Notification and Tracking of AF Development","phase":"NA","overall_status":"RECRUITING","enrollment_count":14726,"lead_sponsor_name":"National Defense Medical Center, Taiwan","has_results":false},{"nct_id":"NCT03388281","title":"Morbidity, Mortality and Gender Differences in Patients With Pacemakers","phase":"","overall_status":"COMPLETED","enrollment_count":11444,"lead_sponsor_name":"Medical University of Vienna","has_results":false},{"nct_id":"NCT07123896","title":"Arrhythmia Cohort Study","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":10000,"lead_sponsor_name":"Beijing Anzhen Hospital","has_results":false},{"nct_id":"NCT07096973","title":"Cardiac REhabilitation COhort at the Medicine Campus DaVos to invEstigate Recovery","phase":"","overall_status":"RECRUITING","enrollment_count":10000,"lead_sponsor_name":"Hochgebirgsklinik Davos","has_results":false},{"nct_id":"NCT06324682","title":"ConTempoRary Cardiac Stimulation in Clinical practicE: lEft, BivEntriculAr, Right, and conDuction System Pacing","phase":"","overall_status":"RECRUITING","enrollment_count":8400,"lead_sponsor_name":"University Hospital of Ferrara","has_results":false},{"nct_id":"NCT04750798","title":"An Observational Post-marketing Study Using Commercially Approved Biosense Webster (BWI) Medical Devices for the Treatment of Participants With Cardiac Arrhythmias","phase":"","overall_status":"RECRUITING","enrollment_count":8000,"lead_sponsor_name":"Biosense Webster, Inc.","has_results":false},{"nct_id":"NCT05521451","title":"Clinical Cohort Study - TRUST","phase":"","overall_status":"RECRUITING","enrollment_count":5000,"lead_sponsor_name":"Universitätsklinikum Hamburg-Eppendorf","has_results":false},{"nct_id":"NCT04407780","title":"Cardio-Oncology Registry","phase":"","overall_status":"RECRUITING","enrollment_count":5000,"lead_sponsor_name":"European Georges Pompidou Hospital","has_results":false},{"nct_id":"NCT04919902","title":"Prague Registry of Electric Cardioversion","phase":"","overall_status":"UNKNOWN","enrollment_count":5000,"lead_sponsor_name":"Institute for Clinical and Experimental Medicine","has_results":false},{"nct_id":"NCT07020910","title":"Bad Berka Heart Rhythm Registry of Patients With or at Risk of Arrhythmias Treated at Heart Center Bad Berka","phase":"","overall_status":"RECRUITING","enrollment_count":5000,"lead_sponsor_name":"Zentralklinik Bad Berka","has_results":false},{"nct_id":"NCT04345627","title":"Japanese Lead Extraction Registry","phase":"","overall_status":"RECRUITING","enrollment_count":5000,"lead_sponsor_name":"National Cerebral and Cardiovascular Center, Japan","has_results":false},{"nct_id":"NCT07276139","title":"PACEVALUE: Development of a Risk Score to Predict Pacing-Induced Cardiomyopathy in Patients Undergoing Pacemaker or ICD Implantation and Evaluation of Patient Outcomes and Cost-Effectiveness Across Different Healthcare Systems","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":4500,"lead_sponsor_name":"Insel Gruppe AG, University Hospital Bern","has_results":false},{"nct_id":"NCT05324566","title":"Evaluation of ECG Transmission and AI Models Using Apple Watch ECGs and Symptoms Data Collected Using a Mayo iPhone App","phase":"","overall_status":"COMPLETED","enrollment_count":4163,"lead_sponsor_name":"Mayo Clinic","has_results":false},{"nct_id":"NCT04358029","title":"Cardiac Arrhythmias In Patients With Coronavirus Disease (COVID-19)","phase":"","overall_status":"COMPLETED","enrollment_count":4000,"lead_sponsor_name":"Vivek Reddy","has_results":false},{"nct_id":"NCT06804499","title":"Tampere Coronary Artery Disease and Sudden Cardiac Arrest Study","phase":"","overall_status":"RECRUITING","enrollment_count":4000,"lead_sponsor_name":"Tampere Heart Hospital","has_results":false},{"nct_id":"NCT05967546","title":"Deep Learning for Intelligent Identification of Arrhythmias","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":4000,"lead_sponsor_name":"First Affiliated Hospital Xi'an Jiaotong University","has_results":false},{"nct_id":"NCT07354347","title":"Optimal Settings for Anti Tachycardia Pacing (ATP) on ICD","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":3980,"lead_sponsor_name":"Rigshospitalet, Denmark","has_results":false},{"nct_id":"NCT06272396","title":"Relevance of Recording an ECG Trace With a Connected Watch","phase":"NA","overall_status":"RECRUITING","enrollment_count":3000,"lead_sponsor_name":"University Hospital, Bordeaux","has_results":false},{"nct_id":"NCT02668250","title":"Influence of a Multi-parametric Optimization Strategy for General Anesthesia on Postoperative Morbidity and Mortality","phase":"NA","overall_status":"COMPLETED","enrollment_count":2495,"lead_sponsor_name":"Centre Hospitalier Universitaire de Saint Etienne","has_results":false},{"nct_id":"NCT01841242","title":"Comparison of Alcoholic Chlorhexidine 2% Versus Alcoholic Povidone Iodine for Infections Prevention With Cardiac Resynchronization Therapy Device Implantation","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":2272,"lead_sponsor_name":"Centre Hospitalier Universitaire de Saint Etienne","has_results":false},{"nct_id":"NCT00911508","title":"Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial","phase":"NA","overall_status":"COMPLETED","enrollment_count":2204,"lead_sponsor_name":"Mayo Clinic","has_results":true},{"nct_id":"NCT06964464","title":"Comparative Effectiveness of Carvedilol Versus Metoprolol Succinate in Heart Failure Patients With an Implantable Cardioverter Defibrillator","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":2000,"lead_sponsor_name":"University of Rochester","has_results":false},{"nct_id":"NCT05694273","title":"Acute Cerebrovascular Events in Patients Undergoing Catheter Ablation","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":2000,"lead_sponsor_name":"First Affiliated Hospital Xi'an Jiaotong University","has_results":false},{"nct_id":"NCT05452356","title":"Testing VIRTUES Patient Care Sets in Cardiac Patients (VIRTUES Cardiac Care)","phase":"","overall_status":"RECRUITING","enrollment_count":2000,"lead_sponsor_name":"London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's","has_results":false},{"nct_id":"NCT03505801","title":"Confirm Rx Insertable Cardiac Monitor SMART Registry","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":1826,"lead_sponsor_name":"Abbott Medical Devices","has_results":false},{"nct_id":"NCT03243604","title":"cARdiotoxicity Profile of aBIraTeRone in prostAte Cancer : a pharmacoviGilancE Study","phase":"","overall_status":"COMPLETED","enrollment_count":1717,"lead_sponsor_name":"Groupe Hospitalier Pitie-Salpetriere","has_results":false},{"nct_id":"NCT04053816","title":"Prevention of Dysrhythmias on the Cardiac Intensive Care Unit - Does Maintenance of High-normal Serum Potassium Levels Matter","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1684,"lead_sponsor_name":"Barts & The London NHS Trust","has_results":false},{"nct_id":"NCT07501481","title":"Arrhythmic Risk in Myocarditis Outcome Research","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":1500,"lead_sponsor_name":"AZ Sint-Jan AV","has_results":false},{"nct_id":"NCT07336225","title":"CMR-Based Prognostic Study in Patients With Cardiac Implantable Electronic Devices","phase":"","overall_status":"RECRUITING","enrollment_count":1500,"lead_sponsor_name":"Chinese Academy of Medical Sciences, Fuwai Hospital","has_results":false},{"nct_id":"NCT07291544","title":"Management of Supraventricular Tachycardias in Children","phase":"","overall_status":"COMPLETED","enrollment_count":1400,"lead_sponsor_name":"Paris Cardiovascular Research Center (Inserm U970)","has_results":false},{"nct_id":"NCT06061120","title":"Non-invasive Differentiation of Supraventricular Tachyarrhythmia","phase":"","overall_status":"RECRUITING","enrollment_count":1250,"lead_sponsor_name":"RWTH Aachen University","has_results":false},{"nct_id":"NCT07351435","title":"The Caribbean Registry of Extracorporeal Membrane Oxygenation (ECMO) From the University Hospital in Martinique","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":1200,"lead_sponsor_name":"University of Genova","has_results":false},{"nct_id":"NCT03833089","title":"Targeted Potassium Levels for Prevention of ICD Therapy","phase":"PHASE4","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":1200,"lead_sponsor_name":"Rigshospitalet, Denmark","has_results":false},{"nct_id":"NCT03405740","title":"Remote Patient Management of CIEDs","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":1115,"lead_sponsor_name":"Ratika Parkash","has_results":false},{"nct_id":"NCT05175937","title":"REal World Assessment for Patients Implanted With Implantable CardioverTer DefibrIllatOr Using Bluetooth Technology","phase":"","overall_status":"UNKNOWN","enrollment_count":1104,"lead_sponsor_name":"Federico II University","has_results":false},{"nct_id":"NCT07185412","title":"Spanish Registry of Redo Procedures Following Pulmonary Vein Ablation by Pulsed Field Ablation Technology: RESET-PFA","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":1100,"lead_sponsor_name":"Instituto de Investigación Sanitaria Aragón","has_results":false},{"nct_id":"NCT03260244","title":"EnSite Precision Observational Study","phase":"","overall_status":"COMPLETED","enrollment_count":1065,"lead_sponsor_name":"Abbott Medical Devices","has_results":true}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}